Intuitive Surgical, Inc. $ISRG Shares Bought by 1ST Source Bank

1ST Source Bank increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,613 shares of the medical equipment provider’s stock after purchasing an additional 329 shares during the quarter. 1ST Source Bank’s holdings in Intuitive Surgical were worth $6,311,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. Norway Savings Bank boosted its holdings in Intuitive Surgical by 53.4% in the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after purchasing an additional 910 shares in the last quarter. IronOak Wealth LLC. bought a new position in Intuitive Surgical during the second quarter valued at about $1,099,000. Trust Co. of Oklahoma acquired a new stake in shares of Intuitive Surgical in the second quarter worth about $363,000. Amalgamated Bank boosted its stake in shares of Intuitive Surgical by 2.2% during the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after acquiring an additional 1,772 shares in the last quarter. Finally, Neville Rodie & Shaw Inc. increased its holdings in shares of Intuitive Surgical by 11.9% during the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after acquiring an additional 1,110 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $560.00 on Friday. The business has a 50 day simple moving average of $471.89 and a 200 day simple moving average of $501.02. The company has a market capitalization of $200.75 billion, a PE ratio of 74.07, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period last year, the company posted $1.84 earnings per share. The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Craig H. Barratt sold 2,193 shares of the firm’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $548.01, for a total transaction of $1,201,785.93. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Myriam Curet sold 125 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 29th. The shares were sold at an average price of $543.00, for a total value of $67,875.00. The SEC filing for this sale provides additional information. Insiders sold a total of 98,078 shares of company stock valued at $51,445,892 over the last 90 days. Company insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on ISRG. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, October 31st. UBS Group set a $600.00 price objective on shares of Intuitive Surgical and gave the stock a “neutral” rating in a report on Thursday, October 23rd. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research note on Wednesday, October 22nd. Raymond James Financial set a $603.00 target price on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Finally, Argus upped their price target on shares of Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.